Adenosine has been found to be cardioprotective during episodes of cardiac ischemia/reperfusion through activation of the A 1 and possibly A 3 receptors. Therefore, we have investigated whether activation of these receptors can protect also against apoptotic death induced by angiotensin II (Ang II) in neonatal rat cardiomyocyte cultures. Exposure to Ang II (10 nM) resulted in a 3-fold increase in programmed cell death (p < 0.05). Pretreatment with the A 1 adenosine receptor agonist 2-chloro- 
Introduction
Apoptosis has been demonstrated to be an important mechanism in the remodeling process after acute myocardial infarction, and the development of either ischemic or non-ischemic cardiac failure. This phenomenon may contribute to the progression of cardiac dysfunction [1] [2] [3] [4] . Angiotensin II (Ang II) was shown to induce programmed cardiomyocyte death, and therefore may be an important mediator of cellular loss in heart failure and after acute myocardial infarction [5] [6] [7] [8] [9] [10] [11] . Thus, identifying therapies that oppose Ang II-induced apoptosis has important investigative and clinical applications.
Cardiomyocytes and vascular cells readily form, transport, and metabolize the endogenous adenine nucleoside -adenosine, and regulate both interstitial and plasma adenosine concentrations. Four subtypes of membrane adenosine receptors have been identified, termed A 1 , A 2A , A 2B and A 3 [12] . Adenosine has been found to be cardioprotective during episodes of cardiac hypoxia/ischemia [13] [14] [15] [16] . It has been demonstrated that maximal preconditioning-induced cardioprotection requires activation of both A 1 and A 3 adenosine receptors [14, 16] . In addition, it has been shown that repeated activation of adenosine A 1 receptors reduces infarct size [17] . These findings suggest that A 1 adenosine receptor activation may hold promise as a new approach to long-term cardioprotection.
It has been demonstrated that adenosine and Ang II levels are increased in heart failure [18, 19] and the elevated adenosine levels may protect against progression of cardiac dysfunction [20] . Thus, increased adenosine levels in heart failure may protect against programmed myocyte death induced by high levels of Ang II. Therefore, we have investigated whether activation of A 1 adenosine receptors, or A 3 adenosine receptors, can protect against apoptotic death induced by Ang II in neonatal rat cardiomyocyte cultures. We also studied whether cardioprotection is related to intracellular Ca 2+ changes.
Materials and methods

Cardiac cell cultures
Sprague-Dawley rat hearts (1-2 days old) were removed under sterile conditions and washed three times in phosphate buffered saline (PBS) to remove excess blood cells. The hearts were minced to small fragments and then agitated gently in a solution of proteolytic enzymes, RDB (Biological Institute, Ness-Ziona, Israel), which was prepared from a fig tree extract. The RDB was diluted 1:100 in Ca 2+ and Mg 2+ -free PBS at 25°C for a few cycles of 10 min each, as described previously [21] . The mixture was centrifuged at 300 g for 5 min. The supernatant phase was discarded, and the cells were resuspended in Dulbecco's modified Eagle's medium (DMEM) containing 10% horse serum (Biological Industries, Kibbutz Beit Haemek, Israel) and 2% chick embryo extract (Biological Industries). The suspension of the cells was diluted to 1.0 × 10 6 cells/ml, and 1.5 ml were placed in 35-mm plastic culture dishes on collagen/gelatin-coated cover glasses. The cultures were incubated in a humidified atmosphere of 5% CO 2 , 95% air at 37°C. Confluent monolayers exhibiting spontaneous contractions were developed in culture within 2 days.
Before exposure to chemicals the growth medium was replaced with chemically defined medium based on DMEM supplemented with transferin (10 µg/ml), insulin (10 µg/ml), T 4 (0.1 µmol/L) and Bovine Serum Albumin (100 µg/ml).
Experiments with Adenosine A 1 and A 3 receptor agonists and antagonists
CCPA -a selective A 1 adenosine receptor agonist, IB-MECA -a selective A 3 adenosine receptor agonist , CPX -a selective A 1 adenosine receptor antagonist, and MRS1523 -a selective A 3 adenosine receptor antagonist were added to cell cultures. Pretreatment with CCPA and IB-MECA was accomplished by adding these compounds 20 min before exposure of cells to Ang II. In additional experiments CPX and MRS1523 were added 20 min prior to pretreatment with CCPA and IB-MECA respectively. Apoptosis assays were performed after exposure of cardiac cells to chemicals for a period of 24 h.
α-Sarcomeric actin staining
In order to identify cardiomyocytes, cells on coverslips were stained for immunohistochemical demonstration of α-sarcomeric actin using mouse monoclonal anti α-sarcomeric actin (C-5) and goat anti-mouse biotinylated immunoglobulin conjugated with extrAvidin peroxidase. The chromogen 3-amino-9-ethylcarbazole (AEC) was used as described previously [21] .
Feulgen procedure
Cells on coverslips were fixed in EFA (by volume, 75:20:5 of 96% ethanol: 40% neutral formol: acetic acid) for 20 min. Fixed samples were placed in 5N HCl for 60 min at 24°C to hydrolyze DNA and stained with the Schiff reagent as described previously [21] .
In situ apoptosis assay
Apoptotic cells were identified in situ using the terminal deoxynucleotidyl transferase nick-end labeling ('TUNEL'-like) assay as described previously [21] . After fixation in 10% neutral buffered formalin for 20 minutes at room temperature and a permeabilization in 70% ethanol for 30 min at -20°C, the assay was performed on cells on coverslips using the available TdT FragEL DNA fragmentation KIT, according to the manufacturer's recommendations. Biotinylated nucleotides were detected using a streptavidin-horseradish peroxidase conjugate. Chromogenes AEC or DAB-Black (Zymed substrate KIT) reacted with the labeled sample to generate an insoluble colored substrate at the site of DNA fragmentation.
Image analysis of Fuelgen and TUNEL stained cells
The image analysis was performed with Scan-Array 2 Image Analyzer (Galai, Israel). The analyzer consisted of an Axiovert 135TV fluorescent microscope (Zeiss, Germany) and a black and white Sony video camera, interfaced to an image analysis computer. Morphonuclear parameters were computed as described in detail previously [21] . In the present work, the system described the following parameters: AREA -morphometric parameter, which corresponds to the area of the nuclear profile; IOD -the integrated optical density, a densitometric parameter, related to the total DNA content and apoptotic index -percent of apoptotic nuclei.
Fluorescence DNA stains
Cells were analyzed for apoptosis following visualization of the fluorescent DNA-binding dye Hoechst 33342 trihydrochloride trihydrate. The monolayers were rinsed with PBS and then incubated with 10 µg/ml H33342 for 30 min. Nuclei were visualized using fluorescent microscopy and analyzed for apoptotic morphology. An average of 1000 nuclei from random fields was analyzed for each slide. The apoptotic index was calculated as described by Wu [22] . At least three samples were scored per group.
Intracellular calcium measurements
Intracellular free calcium concentration was estimated from indo-1 fluorescence, using the ratio method described by Grynkiewicz et al. [23] . The cardiac cells grown on coverslips were transferred to a chamber on the stage of Zeiss inverted microscope filtered with UV epifluorescence illumination. Indo-1 was excited at 355 nm and the emitted light then split by a dichroic mirror to two photomultipliers (Hamamatsu, Japan) with input filters at 405 and 495 nm. The fluorescence ratio of 405/495 nm, which is proportional to Ca 2+ concentration, was monitored. Assessment of changes in intracellular Ca 2+ concentration was done in all experiments. In addition, intracellular Ca 2+ concentration was measured after exposure of cardiac cells to Ang II in a Ca 2+ -free medium.
Chemicals
CCPA, IB-MECA and CPX were purchased from Research Biochemicals International (Natick, MA, USA). Apoptosis detection system (FragEL Kit) was purchased from Calbiochem (San Diego, CA, USA). Indo-1 was purchased from Teflabs (Texas Fluorescence Lab., USA). Other reagents were purchased from Sigma Chemicals (St. Louis, MO, USA).
Statistical analysis
Results are expressed as mean + S.E. ANOVA and Student's t-test were used in statistical evaluation of the data. Values of p < 0.05 were considered significant.
Results
Characterization of neonatal cardiomyocytes in cell cultures after exposure to Ang II
Primary cultures of neonatal rat myocytes maintained in serum-free medium are depicted in Fig. 1A . Myofibrils within these cells were elongated and uniformly distributed throughout the cell. Individual actin fibrils stained with α-sarcomeric actin antibody demonstrated the typical striated pattern. Each culture dish also contained a small number of dead cells, defined by a condensed granular cytoplasm and pyknotic nucleus. The cardiomyocytes of the Ang II (10 nmol/L) treated cultures showed an increase in myofibril content and moderate hypertrophy. In preliminary experiments myocytes were exposed to Ang II at concentrations of 1-1000 nmol/L for a period of 24 h (in serum-free medium) and only a weak dose-dependence response, was observed on apoptotic activity. Therefore, concentrations of 10-100 nmol/L of Ang II were employed in the present study. Morphological features of apoptosis in Ang II treated myocytes include nuclear condensation and fragmentation, blebbing of plasma membrane, shrinking, retraction and condensation of cytoplasm (Figs 1B and 1C) .
Fuelgen and Hoechst stainings demonstrated an increase in the number of apoptotic cells after exposure of cardiomyocytes to Ang II (10 nmol/L) for 24 h (Figs 2B and 3B) .
The apoptotic index (percent of apoptotic nuclei) of Feulgen-stained cells is shown in Fig. 4 . Ang II (10-100 nmol/ L) caused a 3-fold increase in apoptotic cells (from 2.4 ± 1.3% in the control cells to 6.3 ± 3.3 and 7.6 ± 2.8% in the 10 and 100 nmol/L of Ang II treated cells respectively, p < 0.05). Analysis of the fluorescent morphology of Hoechst stained cells shows that Ang II (10-100 nmol/L) caused a marked increase in apoptotic cell death (from 2.6 ± 0.65% in the control cells to 8.8 ± 2.9 and 10.2 ± 2.6% in the 10 and 100 nmol/ L of Ang II treated cells respectively, p < 0.05) (Fig. 4) .
To further examine the cells that contained fragmented nuclear DNA typical of apoptosis, we performed an in situ assay based on end-labeling of DNA strand breaks by the TUNEL-like method (Fig. 5) . TUNEL positive cells were obtained following Ang II treatment (Fig. 5B ) confirming our results with the Fuelgen and Hoechst stainings. The apoptotic index of TUNEL-stained cells is shown in Fig. 4 . Ang II (10-100 nmol/L) caused a 4-fold increase in apoptotic cell death (from 1.4 ± 0.28% in the control cells to 5.8 ± 1.24% and 6.5 ± 1.54% in the 10 and 100 nmol/L of Ang II treated cells respectively, p < 0.05).
Effects of adenosine A 1 and A 3 receptor ligands on cardiomyocyte death
We investigated the possible protective effects of adenosine 
Effects of Ang II and adenosine agonists on intracellular Ca 2+ concentrations
Control myocytes demonstrated spontaneous, regular beating activity and Ca 2+ transients. Exposure of myocytes to Ang II (1-1000 nmol/L) caused an increase in the concentration of intracellular free Ca 2+ in concentration-dependent manner. The drug produced a rapid rise followed by a sustained increase in Ca
2+
, that lasted 60-200 sec (Fig. 6A) . Treatment of cells in a Ca 2+ -free medium did not abolish the intracellular Ca 2+ rise induced by Ang II, indicating that Ca 2+ elevation following response to Ang II arises from intracellular stores (Fig. 6D) . The effect was not inhibited by pretreatment with either the adenosine receptor agonist CCPA (1 µmol/L) or the A 3 adenosine receptor agonist IB-MECA (0.1 µmol/L) ( Figs 6B and 6C) .
Discussion
In the present study we have demonstrated that activation of the adenosine A 1 receptor can significantly attenuate Ang IImediated apoptosis in cardiocytes, while activation of the adenosine A 3 receptor results in partial cardioprotection.
The vasopeptide Ang II acts on its target tissues via two subtypes membrane-bound receptors: AT 1 and AT 2 [24] . The AT 1 receptor belongs to the seven membrane-domain G protein-coupled receptor family, bound to heterotrimaric Gq protein. The coupling of the AT 2 receptor to the G protein family are less clearly established [25] . Recently, we have shown that stimulation of both receptor 54b types is required for the apoptotic effects of Ang II, while blockage of either the AT 1 or AT 2 receptor subtypes results in inhibition of Ang II-induced apoptosis [11] . Adenosine also exerts its biological effects via the activation of the G protein-coupled recep- tor family [12] . Evidence supports functional interaction between adenosine and AT 1 receptors in the regulation of vascular resistance; stimulation of both receptors induces vasoconstriction [26] . Weihprecht et al. [27] , demonstrated that blocking the A 1 adenosine receptor with CPX attenuated the Ang II-induced afferent arteriolar renal vasoconstriction. Moreover, Liu et al. [28] showed that ischemic preconditioning in the rabbit heart is mediated through both AT 1 and adenosine A 1 receptors. Thus, in the vascular tree and in the process of ischemic preconditioning it seems that adenosine and Ang II cooperate in a mutually dependent and synergistic fashion. In contrast, we have demonstrated that in cardiac cells adenosine opposes the apoptotic effect of Ang II. The anti-apoptotic effect of adenosine does not involve the Ang II receptors, since pretreatment with either the A 1 adenosine receptor antagonist -CPX or the A 3 adenosine receptor antagonist -MRS1523 did not abolish Ang II induced programmed cardiomyocytes. Recently, it has been shown that activation of both adenosine receptor subtypes results in a decrease in intracellular energy supply (manifested by a decrease in the content of adenosine triphosphate (ATP) in cardiomyocytes), while simultaneously adequate amounts of ATP are preserved for maintenance of mitochondrial metabolism on a level sufficient for survival [29] . Apoptosis is an active, energy-consuming process, which is dependent on intracellular supply of ATP. Thus, a possible mechanism for the inhibition of the proapoptotic effect of Ang II by activation of adenosine receptors is a reduction of intracellular energy supply to a level insufficient for the apoptotic process. Our findings that adenosine protects against programmed myocyte death in heart cultures were confirmed in each apoptosis assay. Cardioprotective effect against apoptosis through activation of adenosine receptors was validated using the A 1 and A 3 receptors antagonists CPX and MRS1523 respectively. Adenosine metabolism is changed in patients with heart failure and increases in adenosine levels may aid to reduce the severity of cardiac dysfunction [18, 19] . Since Ang II levels are also elevated in heart failure, it is possible that endogenous adenosine is increased to protect the cardiac cells from apoptosis in this condition.
We have attempted to determine whether the induction of programmed cardiomyocyte death by Ang II, and cardioprotection induced by adenosine agonists are related to changes in cytosolic Ca 2+ . The effect of Ang II on intracellular Ca 2+ concentration was immediate and lasted 40-200 sec. Since treatment of cells in a calcium-free medium failed to prevent the intracellular Ca 2+ elevation induced by Ang II, it can be concluded that the Ca 2+ arises from intracellular stores e.g. -the sarcoplasmic reticulum. The calcium rise induced by Ang II was concentration-dependent and had an affect on the whole population of cultured myocytes. Pretreatment with the adenosine agonists had no effect on the Ang II-induced intracellular Ca 2+ rise, while it blunted Ang II-induced apoptosis. Thus, it seems that prevention of Ang II-induced apoptosis is not mediated through changes in intracellular Ca 2+ . Our findings present unequivocal data that adenosine confers cardioprotection against Ang II-induced apoptosis. This effect may play a role in pathological conditions in which both endogenous adenosine and Ang II levels are increased, e.g. heart failure and acute myocardial infarction. Recognition of the factors responsible for the initiation or prevention of programmed cell death may eventually lead to therapeutic interventions, as long acting adenosine A 1 receptor agonists are currently undergoing clinical development.
